NetworkNewsBreaks – Pressure BioSciences Inc.’
Post# of 1354
(Total Views: 231)
Posted On: 10/23/2019 4:59:37 PM
NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
Pressure BioSciences’ (OTCQB: PBIO) patented pressure cycling technology (“PCT”) platform was recently described as an integral part of women’s cancer research efforts during a presentation at the International Gynecologic Cancer Society conference in Brazil. An article discussing the company reads, “Pressure BioSciences’ PCT platform, as an integral part of the analytical trio, prepares the excised cells for micro-scale quantitative proteomics and phosphoproteomics – the large-scale study of proteins and their phosphorylation-based signaling networks – by provoking rapid and efficient high-quality cellular protein release and preparation from the biopsy samples. The entire sample preparation process is done in the company’s proprietary Barocycler 2320EXT system. . . . The researchers presented an explanation of their working process in searching for ways to combat gynecological cancers during a core session of the annual International Gynecologic Cancer Society (“IGCS”) conference last month in Rio de Janeiro, Brazil. Dr. Larry Maxwell, a gynecologic oncologist and the OB-GYN chairman at Northern Virginia’s Inova Fairfax Hospital, described the PCT-based Barocycler system technology provided by Pressure BioSciences as ‘an essential requirement for our novel workflow in meeting our goals’ in his presentation to the IGCS.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences’ (OTCQB: PBIO) patented pressure cycling technology (“PCT”) platform was recently described as an integral part of women’s cancer research efforts during a presentation at the International Gynecologic Cancer Society conference in Brazil. An article discussing the company reads, “Pressure BioSciences’ PCT platform, as an integral part of the analytical trio, prepares the excised cells for micro-scale quantitative proteomics and phosphoproteomics – the large-scale study of proteins and their phosphorylation-based signaling networks – by provoking rapid and efficient high-quality cellular protein release and preparation from the biopsy samples. The entire sample preparation process is done in the company’s proprietary Barocycler 2320EXT system. . . . The researchers presented an explanation of their working process in searching for ways to combat gynecological cancers during a core session of the annual International Gynecologic Cancer Society (“IGCS”) conference last month in Rio de Janeiro, Brazil. Dr. Larry Maxwell, a gynecologic oncologist and the OB-GYN chairman at Northern Virginia’s Inova Fairfax Hospital, described the PCT-based Barocycler system technology provided by Pressure BioSciences as ‘an essential requirement for our novel workflow in meeting our goals’ in his presentation to the IGCS.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)